| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 | Mar 6, 2024 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Director | Buy | 95.0 | +40,000 | 100.00% | ✗ | $176.2K |
| Aug 9, 2022 | Aug 11, 2022 | Moderna, Inc. | CFO | Sell | 46.3 | -164 | -5.43% | ✗ | $28.5K |
| May 9, 2022 | May 11, 2022 | Moderna, Inc. | CFO | Sell | 46.3 | -156 | -5.70% | ✗ | $20.9K |
| Feb 9, 2022 | Feb 11, 2022 | Moderna, Inc. | CFO | Sell | 42.5 | -619 | -20.56% | ✗ | $98.4K |
| Nov 25, 2019 | Nov 25, 2019 | AMGEN INC | CFO | Sell | 17.5 | -8,737 | -15.03% | ✗ | $2M |
| May 3, 2019 | May 7, 2019 | AMGEN INC | CFO | Sell | 90.0 | +3,716 | 6.86% | ✗ | $140.3K |
| May 1, 2019 | May 3, 2019 | AMGEN INC | CFO | Sell | 22.5 | -746 | -1.36% | ✗ | $133.8K |
| Mar 22, 2019 | Mar 25, 2019 | AMGEN INC | CFO | Sell | 17.5 | -8,040 | -12.77% | ✗ | $1.5M |
| Jan 30, 2019 | Feb 1, 2019 | AMGEN INC | CFO | Sell | 22.5 | -528 | -1.12% | ✗ | $101.4K |
| Aug 1, 2018 | Aug 2, 2018 | AMGEN INC | CFO | Sell | 17.5 | -7,382 | -12.39% | ✗ | $1.5M |
| May 3, 2018 | May 7, 2018 | AMGEN INC | CFO | Sell | 22.5 | -773 | -1.29% | ✗ | $131K |
| Mar 23, 2018 | Mar 27, 2018 | AMGEN INC | CFO | Sell | 17.5 | -7,549 | -11.95% | ✗ | $1.3M |
| Jan 30, 2018 | Jan 30, 2018 | AMGEN INC | CFO | Sell | 22.5 | -496 | -1.03% | ✗ | $98.2K |
| Aug 1, 2017 | Aug 1, 2017 | AMGEN INC | CFO | Sell | 17.5 | -7,562 | -13.63% | ✗ | $1.3M |